Patients with vascular anomalies have conditions of the veins, arteries and the lymphatic system that can be classified as tumors (benign and malignant) and vascular malformations (congenital anomalies of the vasculature). These conditions, which can range in complexity, can cause pronounced visible deformities and disfigurement, impede critical organ functions such as swallowing or breathing, or cause severe pain interfering with one’s quality of life. It has become clear that patients with more complex forms of vascular anomalies benefit from multidisciplinary collaboration among various specialists from numerous disciplines, including cardiology, dermatology, genetics, hematology, interventional radiology, oncology, pathology, pulmonology, and surgery. This lecture will provide an overview of how comprehensive, multidisciplinary care can benefit patients with these complex conditions as well as updates on Diagnosis, Phenotype/Genotype Correlation of Disease, Innovative Interventional Therapeutics options and Translational Research underway that can lead to New Drug Development.
- Describe the latest disease classification for Vascular Anomalies
- Discuss disease genotype and phenotypes
- Explain new interventional and Therapeutic options for treatment
- Summarize the translational research underway that can improve outcomes for patients with vascular anomalies
Contact: Shelly Norbury, (856) 397-5588, firstname.lastname@example.org
ACCME Accreditation Statement: Children’s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Approval of AMA PRA Category 1 Credit(s) for this lecture is pending. If approved, physicians can claim CME credit commensurate with the extent of their participation in the activity for free.